Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia.
Ball L, Bredius R, Lankester A, Schweizer J, van den Heuvel-Eibrink M, Escher H, Fibbe W, Egeler M. Ball L, et al. Among authors: egeler m. Leukemia. 2008 Jun;22(6):1256-7. doi: 10.1038/sj.leu.2405013. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972946 No abstract available.
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK, Brand R, van Biezen A, Finke J, Boogaerts M, Fauser AA, Egeler M, Cahn JY, Arnold R, Biersack H, Niederwieser D, de Witte T. Al-Ali HK, et al. Among authors: egeler m. Leukemia. 2007 Sep;21(9):1945-51. doi: 10.1038/sj.leu.2404774. Epub 2007 Jul 5. Leukemia. 2007. PMID: 17611571
Will post-transplantation cell therapies for pediatric patients become standard of care?
Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, Pulsipher MA, Nierkens S, Schultz K, Handgretinger R, Grupp SA, Boelens JJ, Bollard CM; Westhafen Intercontinental Group. Lankester AC, et al. Among authors: egeler m. Biol Blood Marrow Transplant. 2015 Mar;21(3):402-11. doi: 10.1016/j.bbmt.2014.07.018. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2015. PMID: 25064748 Free article. Review.
Late mortality after hematopoietic SCT for a childhood malignancy.
Schechter T, Pole JD, Darmawikarta D, Doyle J, Ali M, Egeler M, Gassas A, Irwin MS, Greenberg M, Nathan PC. Schechter T, et al. Among authors: egeler m. Bone Marrow Transplant. 2013 Oct;48(10):1291-5. doi: 10.1038/bmt.2013.64. Epub 2013 May 13. Bone Marrow Transplant. 2013. PMID: 23665822
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation.
Bartelink IH, Bredius RG, Belitser SV, Suttorp MM, Bierings M, Knibbe CA, Egeler M, Lankester AC, Egberts AC, Zwaveling J, Boelens JJ. Bartelink IH, et al. Among authors: egeler m. Biol Blood Marrow Transplant. 2009 Feb;15(2):231-41. doi: 10.1016/j.bbmt.2008.11.022. Biol Blood Marrow Transplant. 2009. PMID: 19167683 Free article.
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J, Bernard F, van Noesel M, Barkaoui M, Bardet O, Mura R, Arico M, Piguet C, Gandemer V, Armari Alla C, Clausen N, Jeziorski E, Lambilliote A, Weitzman S, Henter JI, Van Den Bos C; Salvage Group of the Histiocyte Society. Donadieu J, et al. Blood. 2015 Sep 17;126(12):1415-23. doi: 10.1182/blood-2015-03-635151. Epub 2015 Jul 20. Blood. 2015. PMID: 26194764 Free PMC article. Clinical Trial.
26 results